Trying to Assess Reimbursement Impact based on Revenue Code Change.
A recommendation was made by our consultants to update Revenue Codes on implants from 272 to 278. We did our own research and confirmed that it made sense to do so. While it would not increase payments from Medicare, we were able to see wording in our commercial payers that executing the above recommendation could increase reimbursement.
Our contracts management team is new, we are using older technology and/or we are in process a obtaining the talent to answer the following question.
Until then, I was wondering would anyone know how to tell me a basic concept of how to create a quick net revenue impact analysis based on certain Implants (CDMs) that moved from RevCode 272 to 278?
P.S. I understand how hard it is perform Net Rev impact analysis since it is based on account... but wanted to ask here just in case.